Mechanisms of antimelanoma effect of oat β-glucan supported by electroporation

Bioelectrochemistry. 2018 Oct:123:255-259. doi: 10.1016/j.bioelechem.2018.06.005. Epub 2018 Jun 6.

Abstract

There are still not specified mechanisms how beta-glucan molecules are transported into cells. Supposing, beta-glucan toxicity against tumor cells may be related to the overexpression of the transporter responsible for the transport of glucose molecules in the cells. In this case, glucans - polymers composed of glucose units are much more up-taken by tumor than normal cells. Increased GLUT1 (Glucose Transporter Type 1) expression has been demonstrated earlier in malignant melanomas. GLUT1 expression promotes glucose uptake and cell growth in that cells. Also, in human melanoma tissues a significant correlation between GLUT1 expression and mitotic activity was found. The aim of the study was to verify if oat β-glucan (OβG) is delivered into cells by GLUT-1 membrane protein. To check it out we blocked GLUT1 transporters by an inhibitor WZB117 and then we investigated cells viability with and without reversible electroporation (EP). The obtained results bring us to elucidate the mechanism of transport of the OβG into the cells is GLUT-1 dependent and moreover can be supported by EP method.

Keywords: GLUT1; Melanoma; Oat beta-glucan; WZB117.

MeSH terms

  • Antineoplastic Agents / pharmacokinetics*
  • Antineoplastic Agents / pharmacology*
  • Cell Line, Tumor
  • Electroporation* / methods
  • Glucose / metabolism
  • Glucose Transporter Type 1 / metabolism
  • Humans
  • Melanoma / drug therapy*
  • Melanoma / metabolism
  • Melanoma / pathology
  • beta-Glucans / pharmacokinetics*
  • beta-Glucans / pharmacology*

Substances

  • Antineoplastic Agents
  • Glucose Transporter Type 1
  • SLC2A1 protein, human
  • beta-Glucans
  • beta-glucan, (1-3)(1-4)-
  • Glucose